15. Exp Mol Pathol. 2018 Jun;104(3):161-169. doi: 10.1016/j.yexmp.2018.03.006. Epub2018 Mar 31.Shallow whole genome sequencing for robust copy number profiling offormalin-fixed paraffin-embedded breast cancers.Chin SF(1), Santonja A(2), Grzelak M(3), Ahn S(4), Sammut SJ(5), Clifford H(3),Rueda OM(6), Pugh M(7), Goldgraben MA(8), Bardwell HA(3), Cho EY(9), ProvenzanoE(10), Rojo F(11), Alba E(12), Caldas C(13).Author information: (1)Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University ofCambridge, Robinson Way, Cambridge CB2 0RE, UK; Department of Oncology,University of Cambridge, Cambridge CB2 2QQ, UK; Cancer Research UK CambridgeCancer Centre, Cambridge CB2 0QQ, UK. Electronic address:suet-feung.chin@cruk.cam.ac.uk.(2)Medical Oncology Service, Hospital Universitario Regional y Virgen de laVictoria, Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain; Laboratorio de Biología Molecular del Cáncer, Centro de InvestigacionesMédico-Sanitarias (CIMES), Universidad de Málaga, Málaga, Spain.(3)Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University ofCambridge, Robinson Way, Cambridge CB2 0RE, UK.(4)Department of Pathology, Seoul National University Bundang Hospital, 82,Gumi-ro 173 Beon-gil, Bundang-gu, Seongnam, Gyeonggi 13620, Republic of Korea;Inivata, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK.(5)Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University ofCambridge, Robinson Way, Cambridge CB2 0RE, UK; Department of Oncology,University of Cambridge, Cambridge CB2 2QQ, UK; Cancer Research UK CambridgeCancer Centre, Cambridge CB2 0QQ, UK.(6)Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University ofCambridge, Robinson Way, Cambridge CB2 0RE, UK; Cancer Research UK CambridgeCancer Centre, Cambridge CB2 0QQ, UK.(7)Inivata UK, The Portway Building, Granta Park, Cambridge CB21 6GS, UK.(8)Department of Medical Genetics, University of Cambridge, Cambridge CB2 0QQ,UK.(9)Department of Pathology and Translational Genomics, Samsung Medical Center,Sungkyunkwan University School of Medicine, 50 Irwon-dong, Gangnam-gu, Seoul135-710, Republic of Korea.(10)Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust, NIHR Cambridge Biomedical Research Centre, Cambridge CB22QQ, UK; Cancer Research UK Cambridge Cancer Centre, Cambridge CB2 0QQ, UK.(11)Pathology Department, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD), Madrid, Spain; GEICAM-Spanish Breast Cancer Research Group,Madrid, Spain.(12)Medical Oncology Service, Hospital Universitario Regional y Virgen de laVictoria, Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain; GEICAM-Spanish Breast Cancer Research Group, Madrid, Spain; Laboratorio deBiología Molecular del Cáncer, Centro de Investigaciones Médico-Sanitarias(CIMES), Universidad de Málaga, Málaga, Spain.(13)Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University ofCambridge, Robinson Way, Cambridge CB2 0RE, UK; Department of Oncology,University of Cambridge, Cambridge CB2 2QQ, UK; Cambridge Breast Unit,Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust, NIHR Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK; Cancer Research UKCambridge Cancer Centre, Cambridge CB2 0QQ, UK. Electronic address:carlos.caldas@cruk.cam.ac.uk.Pathology archives with linked clinical data are an invaluable resource fortranslational research, with the limitation that most cancer samples areformalin-fixed paraffin-embedded (FFPE) tissues. Therefore, FFPE tissues are animportant resource for genomic profiling studies but are under-utilised due tothe low amount and quality of extracted nucleic acids. We profiled the copynumber landscape of 356 breast cancer patients using DNA extracted FFPE tissuesby shallow whole genome sequencing. We generated a total of 491 sequencinglibraries from 2 kits and obtained data from 98.4% of libraries with 86.4% being of good quality. We generated libraries from as low as 3.8 ng of input DNA andfound that the success was independent of input DNA amount and quality,processing site and age of the fixed tissues. Since copy number alterations (CNA)play a major role in breast cancer, it is imperative that we are able to use FFPEarchives and we have shown in this study that sWGS is a robust method to do such profiling.Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.DOI: 10.1016/j.yexmp.2018.03.006 PMCID: PMC5993858PMID: 29608913 